Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians
The Bristol Myers Squibb Foundation, together with its partners, National Medical Fellowships and the American Association for Cancer Research, has announced the first group of 52 physicians selected for its Diversity in Clinical Trials Career Development Program. The early-stage investigators are the first of 250 community-oriented clinical trialists who will be trained through the program by 2027.
The 52 physicians selected by an independent selection committee are an accomplished group working at a broad range of healthcare institutions in 22 states across the U.S. The physicians include 34 women and 18 men who represent a diverse cross section of races and ethnicities and bring a widely varied perspective and range of experiences to the program, as well as to their therapeutic focus areas of cancer (hematologic or solid tumors), immunologic disorders and cardiovascular diseases.
The first cohort of scholars will begin their two-year participation in October 2021 with a program orientation, followed in early November by a six-day intensive educational workshop on clinical research, called BMSF-AACR Design and Implementation of Clinical Trials Workshop.
More on the first physicians in the Diversity in Clinical Trials Career Development Program
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
